
ATP13A3 antibody immunohistochemistry of formalin-fixed and paraffin-embedded human bladder carcinoma followed by peroxidase-conjugated secondary antibody and DAB staining.

ATP13A3 Antibody western blot of HepG2 cell line lysates (35 ug/lane). The ATP13A3 antibody detected the ATP13A3 protein (arrow).

ATP13A3 Antibody flow cytometry of HepG2 cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.